BDBM664492 (2R,3R,4S,5R,6R)-6-((1-(2-oxabicyclo[2.1.1]hexan-4-yl)-1H-1,2,3- triazol-4-yl)methyl)-4-(4-(4-chloro-2,3-difluorophenyl)-1H-1,2,3-triazol-1- yl)-2-(hydroxymethyl)-5-methoxytetrahydro-2H-pyran-3-ol::US20240109930, Example 2.1.44.

SMILES CO[C@@H]1[C@@H](n2cc(-c3ccc(Cl)c(F)c3F)nn2)[C@@H](O)[C@@H](CO)O[C@@H]1Cc1cn(C23COC(C2)C3)nn1

InChI Key InChIKey=NSMJOEGPTITVOK-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 664492   

TargetGalectin-3(Human)
Idorsia Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 664492BDBM664492((2R,3R,4S,5R,6R)-6-((1-(2-oxabicyclo[2.1.1]hexan-4...)
Affinity DataIC50: 30nMAssay Description:Briefly, compounds are serially diluted in DMSO (working dilutions). ASF-coated 384well plates are supplemented with 22.8 μL/well of biotinylate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2024
Entry Details
US Patent

TargetGalectin-1(Human)
Idorsia Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 664492BDBM664492((2R,3R,4S,5R,6R)-6-((1-(2-oxabicyclo[2.1.1]hexan-4...)
Affinity DataIC50: 2.10E+3nMAssay Description:Briefly, compounds are serially diluted in DMSO (working dilutions). ASF-coated 384well plates are supplemented with 22.8 μL/well of biotinylate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/20/2024
Entry Details
US Patent